National Toxicology Program Board of Scientific Counselors; Announcement of Meeting; Request for Comments, 35308-35309 [2021-14238]
Download as PDF
<![CDATA[
35308
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; HIV Vaccine Research and
Design (HIVRAD) Program (P01 Clinical Trial
Not Allowed).
Date: July 29, 2021.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G11A,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: J. Bruce Sundstrom, Ph.D.,
Scientific Review Officer, Scientific Review
Program, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G11A,
Rockville, MD 20852, 240–669–5045,
sundstromj@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 28, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–14173 Filed 7–1–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Toxicology Program Board of
Scientific Counselors; Announcement
of Meeting; Request for Comments
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
This notice announces the
next meeting of the National Toxicology
Program (NTP) Board of Scientific
Counselors (BSC). The BSC, a federally
chartered, external advisory group
composed of scientists from the public
and private sectors, will review and
provide advice on programmatic
activities. This meeting is a virtual
meeting and is open to the public.
Written comments will be accepted and
registration is required to present oral
comments. Information about the
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
17:12 Jul 01, 2021
Jkt 253001
meeting and registration are available at
https://ntp.niehs.nih.gov/go/165.
DATES:
Meeting: Scheduled for August 4,
2021, 12:30 p.m.–5:00 p.m. Eastern
Daylight Time (EDT).
Written Public Comment
Submissions: Deadline is July 28, 2021.
Registration for Oral Comments:
Deadline is July 28, 2021.
ADDRESSES:
Meeting web page: The preliminary
agenda, registration, and other meeting
materials are available at https://
ntp.niehs.nih.gov/go/165.
Virtual Meeting: The URL for viewing
the virtual meeting will be provided on
the meeting web page the day before the
meeting.
FOR FURTHER INFORMATION CONTACT: Dr.
Sheena Scruggs, Designated Federal
Official for the BSC, Office of Policy,
Review, and Outreach, Division of NTP,
NIEHS, P.O. Box 12233, K2–03,
Research Triangle Park, NC 27709.
Phone: 984–287–3355, Fax: 301–451–
5759, Email: sheena.scruggs@nih.gov.
Hand Deliver/Courier address: 530
Davis Drive, Room K2126, Morrisville,
NC 27560.
SUPPLEMENTARY INFORMATION: The BSC
will provide input to the NTP on
programmatic activities and issues. The
preliminary agenda topics include
presentations from two of the Division
of the National Toxicology Program
(DNTP)’s research program areas. The
preliminary agenda, roster of BSC
members, background materials, public
comments, and any additional
information, when available, will be
posted on the BSC meeting web page
(https://ntp.niehs.nih.gov/go/165) or
may be requested in hardcopy from the
Designated Federal Official for the BSC.
Following the meeting, summary
minutes will be prepared and made
available on the BSC meeting web page.
Meeting Attendance Registration: The
meeting is open to the public with time
scheduled for oral public comments.
Registration is not required to view the
virtual meeting; the URL for the virtual
meeting is provided on the BSC meeting
web page (https://ntp.niehs.nih.gov/go/
165) the day before the meeting. TTY
users should contact the Federal TTY
Relay Service at 800–877–8339.
Requests should be made at least five
business days in advance of the event.
Written Public Comments: NTP
invites written public comments.
Guidelines for public comments are
available at https://ntp.niehs.nih.gov/
ntp/about_ntp/guidelines_public_
comments_508.pdf.
The deadline for submission of
written comments is July 28, 2021.
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
Written public comments should be
submitted through the meeting web
page. Persons submitting written
comments should include name,
affiliation, mailing address, phone,
email, and sponsoring organization (if
any). Written comments received in
response to this notice will be posted on
the NTP web page, and the submitter
will be identified by name, affiliation,
and sponsoring organization (if any).
Oral Public Comment Registration:
The agenda allows for two formal public
comment periods—one comment period
for each program area (up to 3
commenters, up to 5 minutes per
speaker, per topic). Persons wishing to
make an oral comment are required to
register online at https://
ntp.niehs.nih.gov/go/165 by July 28,
2021. Oral comments will be received
only during the formal comment periods
indicated on the preliminary agenda.
Oral comments will only be by
teleconference line. The access number
for the teleconference line will be
provided to registrants by email prior to
the meeting. Registration is on a firstcome, first-served basis. Each
organization is allowed one time slot
per topic. After the maximum number of
speakers per comment period is
exceeded, individuals registered to
provide oral comment will be placed on
a wait list and notified should an
opening become available. Commenters
will be notified approximately one week
before the meeting about the actual time
allotted per speaker.
If possible, oral public commenters
should send a copy of their slides and/
or statement or talking points to NTPMeetings@icf.com by July 28, 2021.
Meeting Materials: The preliminary
meeting agenda is available on the
meeting web page (https://
ntp.niehs.nih.gov/go/165) and will be
updated one week before the meeting.
Individuals are encouraged to access the
meeting web page to stay abreast of the
most current information regarding the
meeting.
Background Information on the BSC:
The BSC is a technical advisory body
comprised of scientists from the public
and private sectors that provides
primary scientific oversight to the NTP.
Specifically, the BSC advises the NTP
on matters of scientific program content,
both present and future, and conducts
periodic review of the program for the
purpose of determining and advising on
the scientific merit of its activities and
their overall scientific quality. Its
members are selected from recognized
authorities knowledgeable in fields such
as toxicology, pharmacology, pathology,
epidemiology, risk assessment,
carcinogenesis, mutagenesis, cellular
E:\FR\FM\02JYN1.SGM
02JYN1
Federal Register / Vol. 86, No. 125 / Friday, July 2, 2021 / Notices
biology, computational toxicology,
neurotoxicology, genetic toxicology,
reproductive toxicology or teratology,
and biostatistics. Members serve
overlapping terms of up to four years.
The BSC usually meets periodically.
The authority for the BSC is provided by
42 U.S.C. 217a, section 222 of the Public
Health Service Act (PHS), as amended.
The BSC is governed by the
provisions of the Federal Advisory
Committee Act, as amended (5 U.S.C.
app.), which sets forth standards for the
formation and use of advisory
committees.
[FR Doc. 2021–14222 Filed 7–1–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2020–0016]
Dated: June 29, 2021.
Brian R. Berridge,
Associate Director, National Toxicology
Program.
Meetings To Implement Pandemic
Response Voluntary Agreement Under
Section 708 of the Defense Production
Act
[FR Doc. 2021–14238 Filed 7–1–21; 8:45 am]
AGENCY:
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Announcement of meetings.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institute of Mental Health;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel; From
Genomic Association to Causation: A
Convergent Neuroscience Approach for
Neuropsychiatric Disorders (U19).
Date: July 28, 2021.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call).
Contact Person: David W. Miller, Ph.D.,
Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd, Room 6140, MSC 9608,
Bethesda, MD 20892–9608, 301–443–9734,
millerda@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
VerDate Sep<11>2014
17:12 Jul 01, 2021
Jkt 253001
The Federal Emergency
Management Agency (FEMA) is holding
a series of meetings to implement the
Voluntary Agreement for the
Manufacture and Distribution of Critical
Healthcare Resources Necessary to
Respond to a Pandemic.
DATES: The schedule for these meetings
is as follows:
• The first meeting took place on
Tuesday, June 22, 2021, from 2 to 4 p.m.
Eastern Time (ET).
• The second meeting took place on
Wednesday, June 23, 2021, from 11 a.m.
to 1 p.m. ET.
• The third meeting took place on
Tuesday, June 29, 2021, from 2 to 4 p.m.
ET.
• The fourth meeting took place on
Thursday, July 1, 2021, from 2 to 4 p.m.
ET.
• The fifth meeting will take place on
Tuesday, July 20, 2021, from 11 a.m. to
1 p.m. ET.
• The sixth meeting will take place
on Thursday, July 22, 2021, from 2 to 4
p.m. ET.
• The seventh meeting will take place
on Tuesday, August 3, 2021, from 11
a.m. to 1 p.m. ET.
• The eighth meeting will take place
on Thursday, August 5, 2021, from 2 to
4 p.m. ET.
FOR FURTHER INFORMATION CONTACT:
Robert Glenn, Office of Business,
Industry, Infrastructure Integration, via
email at OB3I@fema.dhs.gov or via
phone at (202) 212–1666.
SUPPLEMENTARY INFORMATION: Notice of
these meetings is provided as required
by section 708(h)(8) of the Defense
Production Act (DPA), 50 U.S.C.
4558(h)(8), and consistent with 44 CFR
part 332.
SUMMARY:
National Institutes of Health
lotter on DSK11XQN23PROD with NOTICES1
Dated: June 29, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
35309
The DPA authorizes the making of
‘‘voluntary agreements and plans of
action’’ with representatives of industry,
business, and other interests to help
provide for the national defense.1 The
President’s authority to facilitate
voluntary agreements with respect to
responding to the spread of COVID–19
within the United States was delegated
to the Secretary of Homeland Security
in Executive Order 13911.2 The
Secretary of Homeland Security further
delegated this authority to the FEMA
Administrator.3
On August 17, 2020, after the
appropriate consultations with the
Attorney General and the Chairman of
the Federal Trade Commission, FEMA
completed and published in the Federal
Register a ‘‘Voluntary Agreement,
Manufacture and Distribution of Critical
Healthcare Resources Necessary to
Respond to a Pandemic’’ (Voluntary
Agreement).4 Unless terminated earlier,
the Voluntary Agreement is effective
until August 17, 2025, and may be
extended subject to additional approval
by the Attorney General after
consultation with the Chairman of the
Federal Trade Commission. The
Agreement may be used to prepare for
or respond to any pandemic, including
COVID–19, during that time.
On December 7, 2020, the first plan of
action under the Voluntary
Agreement—the Plan of Action to
Establish a National Strategy for the
Manufacture, Allocation, and
Distribution of Personal Protective
Equipment (PPE) to Respond to COVID–
19 (PPE Plan of Action)—was finalized.5
The PPE Plan of Action established
several sub-committees under the
Voluntary Agreement, focusing on
different aspects of the PPE Plan of
Action.
On May 24, 2021, four additional
plans of action under the Voluntary
Agreement—the Plan of Action to
Establish a National Strategy for the
Manufacture, Allocation, and
Distribution of Diagnostic Test Kits and
other Testing Components to respond to
COVID–19, the Plan of Action to
1 50
U.S.C. 4558(c)(1).
FR 18403 (Apr. 1, 2020).
3 DHS Delegation 09052, Rev. 00.1 (Apr. 1, 2020);
DHS Delegation Number 09052 Rev. 00 (Jan. 3,
2017).
4 85 FR 50035 (Aug. 17, 2020). The Attorney
General, in consultation with the Chairman of the
Federal Trade Commission, made the required
finding that the purpose of the voluntary agreement
may not reasonably be achieved through an
agreement having less anticompetitive effects or
without any voluntary agreement and published the
finding in the Federal Register on the same day. 85
FR 50049 (Aug. 17, 2020).
5 See 85 FR 78869 (Dec. 7, 2020). See also 85 FR
79020 (Dec. 8, 2020).
2 85
E:\FR\FM\02JYN1.SGM
02JYN1
]]>Agencies
[Federal Register Volume 86, Number 125 (Friday, July 2, 2021)]
[Notices]
[Pages 35308-35309]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-14238]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Toxicology Program Board of Scientific Counselors;
Announcement of Meeting; Request for Comments
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the next meeting of the National
Toxicology Program (NTP) Board of Scientific Counselors (BSC). The BSC,
a federally chartered, external advisory group composed of scientists
from the public and private sectors, will review and provide advice on
programmatic activities. This meeting is a virtual meeting and is open
to the public. Written comments will be accepted and registration is
required to present oral comments. Information about the meeting and
registration are available at https://ntp.niehs.nih.gov/go/165.
DATES:
Meeting: Scheduled for August 4, 2021, 12:30 p.m.-5:00 p.m. Eastern
Daylight Time (EDT).
Written Public Comment Submissions: Deadline is July 28, 2021.
Registration for Oral Comments: Deadline is July 28, 2021.
ADDRESSES:
Meeting web page: The preliminary agenda, registration, and other
meeting materials are available at https://ntp.niehs.nih.gov/go/165.
Virtual Meeting: The URL for viewing the virtual meeting will be
provided on the meeting web page the day before the meeting.
FOR FURTHER INFORMATION CONTACT: Dr. Sheena Scruggs, Designated Federal
Official for the BSC, Office of Policy, Review, and Outreach, Division
of NTP, NIEHS, P.O. Box 12233, K2-03, Research Triangle Park, NC 27709.
Phone: 984-287-3355, Fax: 301-451-5759, Email: [email protected].
Hand Deliver/Courier address: 530 Davis Drive, Room K2126, Morrisville,
NC 27560.
SUPPLEMENTARY INFORMATION: The BSC will provide input to the NTP on
programmatic activities and issues. The preliminary agenda topics
include presentations from two of the Division of the National
Toxicology Program (DNTP)'s research program areas. The preliminary
agenda, roster of BSC members, background materials, public comments,
and any additional information, when available, will be posted on the
BSC meeting web page (https://ntp.niehs.nih.gov/go/165) or may be
requested in hardcopy from the Designated Federal Official for the BSC.
Following the meeting, summary minutes will be prepared and made
available on the BSC meeting web page.
Meeting Attendance Registration: The meeting is open to the public
with time scheduled for oral public comments. Registration is not
required to view the virtual meeting; the URL for the virtual meeting
is provided on the BSC meeting web page (https://ntp.niehs.nih.gov/go/165) the day before the meeting. TTY users should contact the Federal
TTY Relay Service at 800-877-8339. Requests should be made at least
five business days in advance of the event.
Written Public Comments: NTP invites written public comments.
Guidelines for public comments are available at https://ntp.niehs.nih.gov/ntp/about_ntp/guidelines_public_comments_508.pdf.
The deadline for submission of written comments is July 28, 2021.
Written public comments should be submitted through the meeting web
page. Persons submitting written comments should include name,
affiliation, mailing address, phone, email, and sponsoring organization
(if any). Written comments received in response to this notice will be
posted on the NTP web page, and the submitter will be identified by
name, affiliation, and sponsoring organization (if any).
Oral Public Comment Registration: The agenda allows for two formal
public comment periods--one comment period for each program area (up to
3 commenters, up to 5 minutes per speaker, per topic). Persons wishing
to make an oral comment are required to register online at https://ntp.niehs.nih.gov/go/165 by July 28, 2021. Oral comments will be
received only during the formal comment periods indicated on the
preliminary agenda. Oral comments will only be by teleconference line.
The access number for the teleconference line will be provided to
registrants by email prior to the meeting. Registration is on a first-
come, first-served basis. Each organization is allowed one time slot
per topic. After the maximum number of speakers per comment period is
exceeded, individuals registered to provide oral comment will be placed
on a wait list and notified should an opening become available.
Commenters will be notified approximately one week before the meeting
about the actual time allotted per speaker.
If possible, oral public commenters should send a copy of their
slides and/or statement or talking points to [email protected] by
July 28, 2021.
Meeting Materials: The preliminary meeting agenda is available on
the meeting web page (https://ntp.niehs.nih.gov/go/165) and will be
updated one week before the meeting. Individuals are encouraged to
access the meeting web page to stay abreast of the most current
information regarding the meeting.
Background Information on the BSC: The BSC is a technical advisory
body comprised of scientists from the public and private sectors that
provides primary scientific oversight to the NTP. Specifically, the BSC
advises the NTP on matters of scientific program content, both present
and future, and conducts periodic review of the program for the purpose
of determining and advising on the scientific merit of its activities
and their overall scientific quality. Its members are selected from
recognized authorities knowledgeable in fields such as toxicology,
pharmacology, pathology, epidemiology, risk assessment, carcinogenesis,
mutagenesis, cellular
[[Page 35309]]
biology, computational toxicology, neurotoxicology, genetic toxicology,
reproductive toxicology or teratology, and biostatistics. Members serve
overlapping terms of up to four years. The BSC usually meets
periodically. The authority for the BSC is provided by 42 U.S.C. 217a,
section 222 of the Public Health Service Act (PHS), as amended.
The BSC is governed by the provisions of the Federal Advisory
Committee Act, as amended (5 U.S.C. app.), which sets forth standards
for the formation and use of advisory committees.
Dated: June 29, 2021.
Brian R. Berridge,
Associate Director, National Toxicology Program.
[FR Doc. 2021-14238 Filed 7-1-21; 8:45 am]
BILLING CODE 4140-01-P
